Literature DB >> 6895636

Determination of ergot alkaloids in plasma by high-performance liquid chromatography and fluorescence detection.

P O Edlund.   

Abstract

Liquid chromatographic methods for the determination of ergotamine and methylergometrine in plasma have been developed. The samples are extracted with an organic solvent at pH 9.0 cleaned by extractions and finally injected on an ODS-Hypersil reversed-phase column with acetonitrile-ammonium carbonate buffer as the mobile phase. THe polarity of solvents used for extraction and the mobile phase are varied with the compounds of interest. Ergocristine is used as internal standard for ergotamine, and methysergide for the determination of methylergometrine. The stability of samples and standard solutions for calibration are discussed. Conditions for high selectivity and sensitivity of detection are given. Concentrations down to 100 pg/ml of plasma can be detected with a 3-ml sample.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895636     DOI: 10.1016/s0378-4347(00)84211-5

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors:  S W Sanders; N Haering; H Mosberg; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Authors:  V L Perrin
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.

Authors:  J J Ibraheem; L Paalzow; P Tfelt-Hansen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

4.  Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.

Authors:  J J Ibraheem; L Paalzow; P Tfelt-Hansen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Pharmacokinetics of methysergide and its metabolite methylergometrine in man.

Authors:  U Bredberg; G S Eyjolfsdottir; L Paalzow; P Tfelt-Hansen; V Tfelt-Hansen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case.

Authors:  P Tfelt-Hansen; J R Ostergaard; I Gøthgen; E Jacobsen; J P Rasmussen; B Husum
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Linear pharmacokinetics of intravenous ergotamine tartrate.

Authors:  J J Ibraheem; L Paalzow; P Tfelt-Hansen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Ergot alkaloids--sources, structures and analytical methods.

Authors:  M Flieger; M Wurst; R Shelby
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.